Evidence-governed research,
ranked and screenable.
General and impersonal investment research. Not personalised investment advice. Forecasts, valuations and model outputs are estimates and may be wrong. See Investment Disclaimer.
Verifiable single-name equity research, macro theses and thematic notes across the NYSE and NASDAQ — each with an explicit claim, the indicators that test it, and a kill switch.
By sector
Top Upside
View all →Largest implied return to triangulated fair value.
| # | Company | Rating | Upside |
|---|---|---|---|
| 1 | Brighthouse FinancialBHF | BUY | +158.4% |
| 2 | PVH Corp.PVH | BUY | +75.4% |
| 3 | Nexstar Media GroupNXST | BUY | +62.1% |
| 4 | TTM TechnologiesTTMI | BUY | +50.4% |
| 5 | Snap Inc. (SNAP)SNAP | HOLD | +50.1% |
Best Risk / Reward
View all →Highest bull-upside to bear-downside ratio.
| # | Company | Rating | Up/down |
|---|---|---|---|
| 1 | Brighthouse FinancialBHF | BUY | 11.1× |
| 2 | Capri HoldingsCPRI | BUY | 9.4× |
| 3 | PVH Corp.PVH | BUY | 7.9× |
| 4 | Wyndham Hotels & ResortsWH | BUY | 6.5× |
| 5 | Dick's Sporting GoodsDKS | BUY | 6.1× |
Highest Quality
View all →Best composite quality score (FCF, balance sheet, ROIC, moat).
| # | Company | Rating | Quality |
|---|---|---|---|
| 1 | Veeva SystemsVEEV | SELL | 98/100 |
| 2 | Visa Inc.V | HOLD | 98/100 |
| 3 | Texas Pacific Land CorporationTPL | HOLD | 98/100 |
| 4 | Charles Schwab CorporationSCHW | SELL | 98/100 |
| 5 | RambusRMBS | BUY | 98/100 |
Largest Margin of Safety (FV)
View all →Biggest triangulated fair-value cushion over price.
| # | Company | Rating | Margin of safety |
|---|---|---|---|
| 1 | Brighthouse FinancialBHF | BUY | +157.6% |
| 2 | PVH Corp.PVH | BUY | +75.6% |
| 3 | Nexstar Media GroupNXST | BUY | +62.3% |
| 4 | Snap Inc. (SNAP)SNAP | HOLD | +50.1% |
| 5 | TTM TechnologiesTTMI | BUY | +49.9% |
Widest Moat
View all →Strongest competitive-moat score.
| # | Company | Rating | Moat |
|---|---|---|---|
| 1 | Visa Inc.V | HOLD | 100/100 |
| 2 | Texas Pacific Land CorporationTPL | HOLD | 100/100 |
| 3 | RambusRMBS | BUY | 100/100 |
| 4 | PrologisPLD | HOLD | 100/100 |
| 5 | PaychexPAYX | SELL | 100/100 |
Biggest House-vs-Consensus
View all →Largest gap between the house target and the street.
| # | Company | Rating | vs street |
|---|---|---|---|
| 1 | Arrowhead PharmaceuticalsARWR | SELL | -80.3% |
| 2 | CytokineticsCYTK | SELL | -79.3% |
| 3 | Cava GroupCAVA | SELL | -77.1% |
| 4 | NovantaNOVT | SELL | -74.5% |
| 5 | Roku, Inc.ROKU | SELL | -68.6% |
Macro & thematic research
Twenty years of gold, silver & copper — and the ten-year theses that follow.
Gold compounded at 16.2% in rand over 21 years; the rand is both a return engine and a shock absorber. Four theses for the decade.
AAPL: a real growth inflection — but the stock has already paid for it
iPhone +22%, China +30%, Services at a record. Real inflection — but triangulated fair value (~$279) sits just below spot. HOLD.
Robinhood Markets: Investment Research
An evidence-governed research report on Robinhood Markets (NASDAQ: HOOD), evaluating the company's competitive positioning, growth strategy, and investment thesis.
ServiceNow: Institutional Investment Research
An evidence-governed research report on ServiceNow, evaluating the company's competitive positioning, AI integration strategy, and investment thesis.
The 2026 Middle East Oil Shock
An in-depth research report examining the potential impact of a Middle East oil shock in 2026, covering supply disruption scenarios, price implications, and portfolio positioning strategies.
Gold Producers: Bull & Bear Case
The structural bull case for gold producers over five years, underpinned by central bank demand, fiscal dominance, and supply constraints. Five tickers with differentiated trading strategies and defined entry criteria.